Human ULBP-1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human ULBP-1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human ULBP-1 |
| Clone | [10K10] |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2 |
| Format | unconjugated |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Neutr |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | ULBP-1, -2, and -3 were originally identified as ligands for the human cytomegalovirus glycoprotein UL16 and designated UL16-binding proteins (ULBP). These proteins are distantly related to major histocompatibility class I (MHC I) molecules, possessing the alpha 1 and alpha 2 Ig-like domains, but lacking the alpha 3 domain. Unlike MHC Class I, they have no capacity to bind peptide or interact with beta2-microglobulin. ULBP-1, -2, and -3 are known to bind to human NKG2D, an activating receptor expressed on NK cells, NKT cells, gamma delta T cells, and CD8+ alpha beta T cells. MULT1 (mouse UL16-binding protein-like Transcript 1) is a 53 kDa, MHC Class I-like molecule that belongs to the mouse family of NKG2D ligands. It is a type I transmembr |
| Immunogen | Antibody Generation: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with Human ULBP-1 recombinant protein. |
| Other Names | [ULBP1; RAET1I], [ULBP1; ULBP1; RAET1I; N2DL1; RAET1I; N2DL-1; NKG2DL1] |
| Gene, Accession # | [ULBP-1], Gene ID: 80329, NCBI: NP_079494.1, UniProt: Q9BZM6 |
| Catalog # | MBS690073 |
| Price | $490 |
| Order / More Info | Human ULBP-1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies